Gilead Sciences gifts another 25,600 vials of Remdesivir to India

May 08, 2021

New Delhi [India], May 8 : India thanked American biopharmaceutical company Gilead Sciences on Saturday for gifting another 25,600 vials of Remdesivir, which is...

Gilead Sciences to start trials of inhaled version of remdesivir

Jun 23, 2020

California [USA], June 23 : US-based biopharmaceutical major Gilead Sciences will soon start clinical trials for inhaled formulation of its anti-viral drug remdesivir used...

Dr Reddy's Labs in licensing pact with Gilead Sciences for Remdesivir

Jun 13, 2020

Hyderabad (Telangana) [India], June 13 : Dr Reddy's Laboratories said on Saturday it has entered into a non-exclusive licensing agreement with Gilead Sciences Inc...

Third consignment of 25000 doses of Remdesivir from Gilead sciences reaches India

May 08, 2021

New Delhi [India], May 8 : The third consignment consisting of 25000 doses of Remdesivir from American biopharmaceutical company Gilead Sciences reached India on...

COVID-19: Another 29,021 vials of Remdesivir sent by Gilead Sciences reaches Mumbai

May 15, 2021

Mumbai (Maharashtra) [India], May 15 : American pharmaceutical company Gilead Sciences sent another 29,021 vials of antiviral drug Remdesivir to India on Saturday in...

US FDA approves remdesivir, first drug to treat COVID-19 patients

Oct 23, 2020

Washington [US], October 23 : The United States Food and Drug Administration (FDA) has approved Remdesivir for the treatment of coronavirus, Al Jazeera reported...